FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

779363004: Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3740409012 Gemtuzumab ozogamicin only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740410019 Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740409012 Gemtuzumab ozogamicin only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3740410019 Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5563581000241114 produit contenant seulement du gemtuzumab ozogamicine sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5563581000241114 produit contenant seulement du gemtuzumab ozogamicine sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gemtuzumab ozogamicin only product in parenteral dose form Is a Product containing only gemtuzumab ozogamicin (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Gemtuzumab ozogamicin only product in parenteral dose form Count of base of active ingredient un false Inferred relationship Existential restriction modifier (core metadata concept)
Gemtuzumab ozogamicin only product in parenteral dose form Is a Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Gemtuzumab ozogamicin only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Gemtuzumab ozogamicin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Gemtuzumab ozogamicin only product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Gemtuzumab ozogamicin only product in parenteral dose form Plays role Antineoplastic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Is a False Gemtuzumab ozogamicin only product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)
Gemtuzumab ozogamicin 5 mg powder for solution for infusion and/or injection vial Is a True Gemtuzumab ozogamicin only product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start